Biocon has declared its third quarter results of FY10. Its consolidated net profit increased 186.88% to Rs 80.9 crore versus Rs 28.2 crore, on year-on-year basis (YoY).
Consolidated net sales went up 45.6% to Rs 635.1 crore from Rs 436.2 crore (YoY). 9M FY10 EPS is at Rs 10.72. Operating profit margin (OPM) declined to 19.9% versus 21.8%.
The numbers were better-than-expectations. CNBC-TV18 was expecting revenues at Rs 557.9 crore, OPM at 20.5% and PAT at Rs 79.52 crore.
Highlights
-Adjusted PAT at Rs 80.89 crore versus Rs 74 crore
-Q3FY09 saw forex loss of Rs 45.8 crore
**Include results of Axicorp from July 1 2009 to Sept 30 2009
**Co concluded acquisition of API business if IDL Specialty Chemicals
Segment wise
-Revenue growth seen from the Pharma segment which increased 50% to Rs 565.7 crore versus Rs 375.4 crore.
-Contract Research also grew 21% to Rs 77.45 crore versus Rs 63.84 crore
-Margins decreased as total expenses increased 49% to Rs 508 crore
-Raw material costs increased 49.6% to Rs 355.6 crore
-Employee costs increased 29% to Rs 63.7 crore and other expenses were up 28% to Rs 73.7 crore
-PAT sustained as there are no forex losses this quarter
-On an APAT level the interest costs fall 25% to Rs 2.72 crore.
-And tax outflow increased to Rs 11.2 crore versus Rs 5.8 crore
| Particulars | Dec-09 | Sep-09 | Jun-09 | Mar-09 | | Net Sales / Interest Earned / Operating Income | 309.84 | 301.1 | 251.58 | 229.72 | | Other Income | 6.14 | 11.34 | 7.13 | 10.12 | | Expenditure | -223.16 | -223.86 | -184.21 | -169.71 | | Interest | -0.36 | -0.26 | -0.75 | -0.9 | | Profit Before Depreciation and Tax | 92.46 | 88.32 | 73.75 | 69.23 | | Depreciation | -20.03 | -19.8 | -19.63 | -19.25 | | Profit before Tax | 72.43 | 68.52 | 54.12 | 49.98 | | Tax | -6.63 | -6.16 | -6.57 | 2.04 | | Profit after Tax | 65.8 | 62.36 | 47.55 | 52.02 | | Extraordinary Items | - | - | - | -27.88 | | Net Profit | 65.8 | 62.36 | 47.55 | 24.14 | | Equity Capital | 100 | 100 | 100 | 100 | |
|
|
|
|
Source: CNBC-TV18
Courtesy moneycontrol.comAlso check
No comments:
Post a Comment